30 studies found for:    "Shigellosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Shigellosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn Shigella Sonnei OSPC-rDT Conjugate Vaccine
Condition: Shigellosis
Intervention: Drug: CP
2 Completed Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Conditions: Immunogenicity;   Shigellosis
Intervention: Biological: Shigella Sonnei O-SPC/rBRU
3 Completed Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults
Condition: Shigellosis
Intervention: Biological: Shigella flexneri 2a whole cell killed vaccine (Sf2aWC)
4 Recruiting Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Intervention: Biological: Shigella flexneri 2a InvaplexAR
5 Completed Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition: Shigellosis
Interventions: Biological: Flexyn2a;   Biological: Placebo;   Biological: Flexyn2a plus adjuvant
6 Completed Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults
Condition: Shigellosis
Interventions: Biological: S. sonnei 1790GAHB;   Biological: Placebo
7 Completed A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.
Condition: Shigellosis
Interventions: Biological: S. sonnei 1790GAHB;   Biological: Placebo
8 Completed Therapeutic Induction of Endogenous Antibiotics
Condition: Shigellosis
Interventions: Biological: Sodium Butyrate;   Biological: Saline
9 Completed
Has Results
Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel
Condition: Shigellosis
Intervention: Biological: Shigella conjugate vaccines
10 Completed The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study
Condition: Shigella Sonnei Infection
Intervention: Other: Shigella sonnei infection
11 Completed Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
Condition: Shigella Infection
Interventions: Biological: WRSs2;   Biological: WRSs3;   Other: Placebo
12 Completed Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
13 Terminated Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
Condition: Shigella
Intervention: Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
14 Terminated Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
15 Not yet recruiting SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers
Conditions: Shigellosis;   Bacillary Dysentery
Interventions: Biological: SF2a-TT15 vaccine;   Biological: SF2a-TT15 vaccine + adjuvant;   Biological: Placebo;   Biological: Placebo + adjuvant
16 Completed Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
Condition: Shigella Infection
Intervention: Biological: SC599
17 Completed Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
Condition: Shigellosis
Intervention: Biological: Invaplex 50 Vaccine
18 Not yet recruiting A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Condition: Shigella Sonnei Infection
Interventions: Biological: S. sonnei vaccine 25 μg;   Biological: S. sonnei vaccine 100 μg;   Biological: Menveo;   Biological: Boostrix
19 Completed Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
Condition: Shigellosis
Intervention: Biological: Shigella vaccine
20 Recruiting Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
Condition: Shigellosis
Interventions: Biological: Flexyn2a;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years